BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31903254)

  • 1. Comparison of long-term outcomes between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma.
    Zhao H; Koyanagi K; Kato K; Ito Y; Itami J; Igaki H; Tachimori Y
    J Thorac Dis; 2019 Nov; 11(11):4654-4662. PubMed ID: 31903254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study.
    Jo YY; Yu J; Song KJ; Jang JY; Yoo YJ; Kim SB; Park SR; Kim YH; Kim HR; Kim JH
    Radiother Oncol; 2021 Sep; 162():112-118. PubMed ID: 34265356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
    Haneda R; Booka E; Ishii K; Kikuchi H; Hiramatsu Y; Kamiya K; Ogawa H; Yasui H; Takeuchi H; Tsubosa Y
    World J Surg; 2021 Jun; 45(6):1835-1844. PubMed ID: 33620541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
    Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
    Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age.
    Mayanagi S; Inoue M; Tokizawa K; Fushiki K; Tsushima T; Yokota T; Yamazaki K; Yasui H; Tsubosa Y
    Thorac Cancer; 2024 Jun; ():. PubMed ID: 38898742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma.
    Chen HS; Lin CH; Wu SC; Wang BY
    Ann Surg Oncol; 2022 Jun; 29(6):3617-3627. PubMed ID: 34994899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma.
    Okamura A; Hayami M; Kozuki R; Takahashi K; Toihata T; Imamura Y; Mine S; Watanabe M
    Esophagus; 2020 Jan; 17(1):59-66. PubMed ID: 31595397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma.
    Ma MW; Gao XS; Gu XB; Xie M; Cui M; Zhang M; Liu L; Yin H; Chen LQ
    World J Surg Oncol; 2018 Aug; 16(1):172. PubMed ID: 30119684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic therapy versus esophagectomy for T1bN0M0 esophageal cancer: A population-based study using propensity score matching.
    Zhu J; Liang X; Chen S; Qin Y; Shen D; Yang X
    Heliyon; 2023 Nov; 9(11):e22189. PubMed ID: 38045191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient selection for salvage surgery after definitive chemoradiotherapy in esophageal squamous cell carcinoma.
    Harada H; Yamashita K; Katada C; Ishiyama H; Soeno T; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Hiki N
    Langenbecks Arch Surg; 2020 Sep; 405(6):767-776. PubMed ID: 32671456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcome After Esophagectomy or Definitive Chemoradiotherapy in Elderly Patients (≥80 Years) With Esophageal Cancer.
    Shimonosono M; Sasaki K; Tsuruda Y; Noda M; Uchikado Y; Arigami T; Matsushita D; Mori S; Kurahara H; Nakajo A; Ohtsuka T
    Anticancer Res; 2022 Aug; 42(8):3953-3961. PubMed ID: 35896243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
    Fukuhara M; Urabe Y; Oka S; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayashi R; Nishibuchi I; Murakami Y; Nagata Y; Tanaka S
    Esophagus; 2023 Jul; 20(3):541-547. PubMed ID: 37027046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
    Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
    Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma.
    Booka E; Haneda R; Ishii K; Kawakami T; Tsushima T; Yasui H; Onoe T; Ogawa H; Tsubosa Y
    Ann Surg Oncol; 2020 Sep; 27(9):3163-3170. PubMed ID: 32314159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy.
    Hayami M; Watanabe M; Ishizuka N; Mine S; Imamura Y; Okamura A; Kurogochi T; Yamashita K
    J Surg Oncol; 2018 May; 117(6):1251-1259. PubMed ID: 29205358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
    Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.